Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (38)
COVID-19 (12)
Type
Type
Guidance (1904)
NICE advice (320)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Advice programme
Advice programme
Evidence summaries (67)
Medtech innovation briefings (253)
Apply filters
Showing 401 to 425 of 2422
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain
IPG739
22 September 2022
22 September 2022
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
TA825
21 September 2022
21 September 2022
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
TA826
21 September 2022
21 September 2022
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia
IPG737
21 September 2022
21 September 2022
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause
IPG738
21 September 2022
21 September 2022
Neuropad for detecting preclinical diabetic peripheral neuropathy
MTG38
10 September 2018
21 September 2022
iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia
MIB306
21 September 2022
21 September 2022
Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas
CG118
23 March 2011
20 September 2022
Melphalan for haematological diseases before allogeneic haematopoietic stem cell transplant (terminated appraisal)
TA822
14 September 2022
14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema
TA824
14 September 2022
14 September 2022
Self-harm: assessment, management and preventing recurrence
NG225
7 September 2022
7 September 2022
Self‑harm
QS34
28 June 2013
7 September 2022
Brolucizumab for treating diabetic macular oedema
TA820
31 August 2022
31 August 2022
Faecal microbiota transplant for recurrent Clostridioides difficile infection
MTG71
31 August 2022
31 August 2022
iFuse for treating chronic sacroiliac joint pain
MTG39
2 October 2018
30 August 2022
Contrast-enhanced spectral mammography for breast cancer
MIB304
30 August 2022
30 August 2022
Differential target multiplexed spinal cord stimulation for chronic lower back and leg pain
MIB305
30 August 2022
30 August 2022
Avalglucosidase alfa for treating Pompe disease
TA821
24 August 2022
24 August 2022
Focal resurfacing implants to treat articular cartilage damage in the knee
IPG734
24 August 2022
24 August 2022
Transcutaneous electrical neuromuscular stimulation for urinary incontinence
IPG735
24 August 2022
24 August 2022
Superficial venous arterialisation for chronic limb threatening ischaemia
IPG736
24 August 2022
24 August 2022
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies
TA819
17 August 2022
17 August 2022
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
TA818
17 August 2022
17 August 2022
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections
HTE2
17 August 2022
17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections
HTE1
17 August 2022
17 August 2022
Previous page
1
…
15
16
Current page
17
18
19
…
97
Page
17
of
97
Next page
Results per page
10
25
50
All
Back to top